These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 19520790)

  • 21. Role of cannabinoid CB1 receptors and Gi/o protein activation in the modulation of synaptosomal Na+,K+-ATPase activity by WIN55,212-2 and delta(9)-THC.
    Araya KA; David Pessoa Mahana C; González LG
    Eur J Pharmacol; 2007 Oct; 572(1):32-9. PubMed ID: 17644088
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The cannabinoid agonist WIN55,212-2 increases intracellular calcium via CB1 receptor coupling to Gq/11 G proteins.
    Lauckner JE; Hille B; Mackie K
    Proc Natl Acad Sci U S A; 2005 Dec; 102(52):19144-9. PubMed ID: 16365309
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mutations in the 'DRY' motif of the CB1 cannabinoid receptor result in biased receptor variants.
    Gyombolai P; Tóth AD; Tímár D; Turu G; Hunyady L
    J Mol Endocrinol; 2015 Feb; 54(1):75-89. PubMed ID: 25510402
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Measurement of β-Arrestin Recruitment at GPCRs Using the Tango Assay.
    Laroche G; Giguère PM
    Methods Mol Biol; 2019; 1947():257-267. PubMed ID: 30969421
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Anandamide-mediated CB1/CB2 cannabinoid receptor--independent nitric oxide production in rabbit aortic endothelial cells.
    McCollum L; Howlett AC; Mukhopadhyay S
    J Pharmacol Exp Ther; 2007 Jun; 321(3):930-7. PubMed ID: 17379772
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cannabinoid agonists increase the interaction between β-Arrestin 2 and ERK1/2 and upregulate β-Arrestin 2 and 5-HT(2A) receptors.
    Franklin JM; Vasiljevik T; Prisinzano TE; Carrasco GA
    Pharmacol Res; 2013 Feb; 68(1):46-58. PubMed ID: 23174265
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differential β-arrestin2 requirements for constitutive and agonist-induced internalization of the CB1 cannabinoid receptor.
    Gyombolai P; Boros E; Hunyady L; Turu G
    Mol Cell Endocrinol; 2013 Jun; 372(1-2):116-27. PubMed ID: 23541635
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Helix 8 Leu in the CB1 cannabinoid receptor contributes to selective signal transduction mechanisms.
    Anavi-Goffer S; Fleischer D; Hurst DP; Lynch DL; Barnett-Norris J; Shi S; Lewis DL; Mukhopadhyay S; Howlett AC; Reggio PH; Abood ME
    J Biol Chem; 2007 Aug; 282(34):25100-13. PubMed ID: 17595161
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparing CB1 receptor GIRK channel responses to receptor internalization using a kinetic imaging assay.
    Andersen HK; Vardakas DG; Lamothe JA; Perault TEA; Walsh KB; Laprairie RB
    Sci Rep; 2024 Aug; 14(1):18314. PubMed ID: 39112591
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Beta-arrestin-mediated activation of MAPK by inverse agonists reveals distinct active conformations for G protein-coupled receptors.
    Azzi M; Charest PG; Angers S; Rousseau G; Kohout T; Bouvier M; Piñeyro G
    Proc Natl Acad Sci U S A; 2003 Sep; 100(20):11406-11. PubMed ID: 13679574
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Signalling profiles of a structurally diverse panel of synthetic cannabinoid receptor agonists.
    Patel M; Manning JJ; Finlay DB; Javitch JA; Banister SD; Grimsey NL; Glass M
    Biochem Pharmacol; 2020 May; 175():113871. PubMed ID: 32088263
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Biased Agonism and Biased Allosteric Modulation at the CB1 Cannabinoid Receptor.
    Khajehali E; Malone DT; Glass M; Sexton PM; Christopoulos A; Leach K
    Mol Pharmacol; 2015 Aug; 88(2):368-79. PubMed ID: 26044547
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Morphine-like opiates selectively antagonize receptor-arrestin interactions.
    Molinari P; Vezzi V; Sbraccia M; Grò C; Riitano D; Ambrosio C; Casella I; Costa T
    J Biol Chem; 2010 Apr; 285(17):12522-35. PubMed ID: 20189994
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Atypical responsiveness of the orphan receptor GPR55 to cannabinoid ligands.
    Kapur A; Zhao P; Sharir H; Bai Y; Caron MG; Barak LS; Abood ME
    J Biol Chem; 2009 Oct; 284(43):29817-27. PubMed ID: 19723626
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cannabinoid receptor 1 ligands revisited: Pharmacological assessment in the ACTOne system.
    Presley CS; Abidi AH; Moore BM
    Anal Biochem; 2016 Apr; 498():8-28. PubMed ID: 26772161
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Screening β-arrestin recruitment for the identification of natural ligands for orphan G-protein-coupled receptors.
    Southern C; Cook JM; Neetoo-Isseljee Z; Taylor DL; Kettleborough CA; Merritt A; Bassoni DL; Raab WJ; Quinn E; Wehrman TS; Davenport AP; Brown AJ; Green A; Wigglesworth MJ; Rees S
    J Biomol Screen; 2013 Jun; 18(5):599-609. PubMed ID: 23396314
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Chemically distinct ligands promote differential CB1 cannabinoid receptor-Gi protein interactions.
    Mukhopadhyay S; Howlett AC
    Mol Pharmacol; 2005 Jun; 67(6):2016-24. PubMed ID: 15749995
    [TBL] [Abstract][Full Text] [Related]  

  • 38. β-Arrestin recruitment and G protein signaling by the atypical human chemokine decoy receptor CCX-CKR.
    Watts AO; Verkaar F; van der Lee MM; Timmerman CA; Kuijer M; van Offenbeek J; van Lith LH; Smit MJ; Leurs R; Zaman GJ; Vischer HF
    J Biol Chem; 2013 Mar; 288(10):7169-81. PubMed ID: 23341447
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Proinflammatory receptor switch from Gαs to Gαi signaling by β-arrestin-mediated PDE4 recruitment in mixed RA synovial cells.
    Jenei-Lanzl Z; Zwingenberg J; Lowin T; Anders S; Straub RH
    Brain Behav Immun; 2015 Nov; 50():266-274. PubMed ID: 26212359
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A novel luminescence-based β-arrestin recruitment assay for unmodified receptors.
    Hauge Pedersen M; Pham J; Mancebo H; Inoue A; Asher WB; Javitch JA
    J Biol Chem; 2021; 296():100503. PubMed ID: 33684444
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.